The Nav1.3 sodium channel, encoded by the SCN3A gene, is highly active during fetal development and is thought to be responsible for nervous system development. Although its expression is reduced in adults, Nav1.3 is highly expressed after injury contributing significantly to increased pain sensitivity. Channel mutations are known to drive hyperexcitability in neruons, making this channel a key therapeutic target for pain management and epilepsy therapeutics.